Renske E. Van Den Bijgaart
Nijmegen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
In Vivo Analysis of Neuroblastoma Targeting Potential of aGD2-SIRPα Fusion Antibodies for Local CD47 Blockade.
Journal: Molecular cancer therapeutics
Published: September 29, 2025
IL2/IL15 Signaling Induces NK Cell Production of FLT3LG, Augmenting Anti-PD-1 Immunotherapy.
Journal: Cancer immunology research
Published: December 06, 2024
Development of aGD2-SIRPα Fusion Antibodies Targeting Neuroblastoma and the Innate Immune Checkpoint Receptor CD47.
Journal: Molecular cancer therapeutics
Published: November 26, 2024
MHC-I and PD-L1 Expression is Associated with Decreased Tumor Outgrowth and is Radiotherapy-inducible in the Murine Head and Neck Squamous Cell Carcinoma Model MOC1.
Journal: Molecular imaging and biology
Published: November 22, 2023
Mechanical high-intensity focused ultrasound creates unique tumor debris enhancing dendritic cell-induced T cell activation.
Journal: Frontiers in immunology
Published: September 06, 2022
Anti-GD2 antibody and Vorinostat immunocombination therapy is highly effective in an aggressive orthotopic neuroblastoma model.
Journal: Oncoimmunology
Published: January 18, 2021
Immune Modulation Plus Tumor Ablation: Adjuvants and Antibodies to Prime and Boost Anti-Tumor Immunity In Situ.
Journal: Frontiers in immunology
Published: October 14, 2020
Tumor ablation plus co-administration of CpG and saponin adjuvants affects IL-1 production and multifunctional T cell numbers in tumor draining lymph nodes.
Journal: Journal for immunotherapy of cancer
Published: April 23, 2020
DC-SCRIPT affects mammary organoids branching morphogenesis by modulating the FGFR1-pERK signaling axis.
Journal: Developmental biology
Published: November 17, 2019
Last Updated: 09/26/2026